NCT03127761View on ClinicalTrials.gov

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

RecruitingOBSERVATIONAL
Enrollment

544

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

May 31, 2027

Study Completion Date

April 30, 2028

Conditions
Multiple Myeloma
Interventions
OTHER

Allogeneic Hematopoietic Stem Cell Transplant

This observational study will compare outcomes of prospectively enrolled HCT recipients with outcomes of a cohort of matched autoHCT controls.

Trial Locations (1)

55401

RECRUITING

Center for International Blood and Marrow Transplant Research, Minneapolis

All Listed Sponsors
collaborator

National Marrow Donor Program

OTHER

lead

Center for International Blood and Marrow Transplant Research

NETWORK